Q2 and H1FY25 Trading Update.


    15 July 2025 07:07:51
  • Source: Sharecast
RNS Number : 0896R
Cirata PLC
15 July 2025
 

15 July 2025

Cirata plc

("Cirata" or the "Company")

 

Q2 and H1FY25 Trading Update

 

Strong H1FY25 bookings growth of 58% YoY

Continued momentum in DI with H1FY25 Bookings up 244% YoY

Q2 cash burn significantly reduced compared to prior years

Divestiture of DevOps assets for $3.5m

Appointment of Chief Revenue Officer

 

 

Cirata plc (LSE: CRTA) today provides an unaudited trading update for the quarter ended 30 June 2025 ("Q2FY25"), alongside further details on operational cash control, sales enhancements, the divestment of DevOps assets, and steps taken to simplify the business and accelerate growth.

 

 

Summary

·    Bookings Metrics

o Total bookings in Q2FY25 of $0.8m (Q2FY24 $1.7m) down 53% YoY, with H1FY25 bookings increased by 58% YoY

o Q2FY25 Data Integration ("DI") bookings of $0.7m (Q2FY24 $0.6m), a rise of 17%YoY with H1 FY25 bookings growth of 244%

·    Commercial Momentum 

o DI renewal with top 5 Canadian Bank  

o New partnership agreement with Microsoft Azure

§ Azure Storage Migration Program ("ASMP")

o 6 contracts signed, of which 2 contracts relate to DI

o DI 95% of total bookings value

·    Divestiture of DevOps Assets

o Cirata announces today that a purchase agreement has been signed with BlueOptima Ltd ("BlueOptima"), a UK-based leading provider of software engineering performance insights, post-period end for gross consideration of up to $3.5m for the sale of Cirata's DevOps assets. This divestiture is expected to close on or around 8 August 2025

·    Financial Discipline and Governance

o Divestiture of DevOps assets, raising up to $3.5m gross proceeds post-period end

o Realigning the cost base from $16-17m run-rate exiting Q1FY25 to an annualized total of $12-13m exiting Q3FY25.

o Q2FY25 cash burn significantly reduced YoY to $2.2m (Q2FY24: $4.2m)

o Unaudited cash position of $6.1m & short-term trade receivables of $1.3m as at 30 June 2025.

 

Outlook

Our outlook communicated in March 2025 remains unchanged, with bookings expected to be back end weighted with a similar profile to FY24 and high growth in the Data Integration business.

 

The divestiture of the DevOps business combined with a further reduction of the annualized overheads will bring cash overheads to approximately $12m-13m exiting Q3FY25, which underpins the sustainability of the business model and provides financial flexibility to invest for growth.

 

The combination of cost-saving actions, DI growth and the recent divestment of assets reaffirms management's previous expectation that a fundraise for working capital is not required in FY25.

 

 

Trading Update

Total bookings in Q2FY25 were $0.8m (Q2FY24: $1.7m), representing a 53% decline YoY. DI bookings were $0.7m in Q2FY25, a rise of 17% YoY.  In total, 6 contracts were signed in the quarter, of which 2 were DI (Q2FY24: 6 contracts signed in total, of which 2 were DI). The 2 DI contracts represented 95% of the total bookings value.

 

For H1FY25 DI bookings were $3.1m, representing growth of 244% YoY with DI accounting for 83% of bookings. Q2FY25 fell short of Cirata's internal plan as certain opportunities slipped into the second half of 2025. The actions taken in January 2025 to strengthen sales execution in the international region have had a positive and immediate impact on progress. However, as outlined in the Q1FY25 Trading Update, execution in North America has been disappointing relative to plan. To that end, further performance improvements have been taken in the quarter to drive sales execution across the Go-To-Market ("GTM") function. GTM leadership across both the US and international markets has been strengthened with the appointment of a new Chief Revenue Officer, Dominic Arcari, on July 1, 2025. Lead generation and pipeline build improved during H1FY25 and these ongoing improvements in pipeline build, alongside enhancements to close planning, increased training and further investment in sales personnel, will be led by Dominic.

 

Establishing greater sales cycle predictability remains a key priority for management to enable Cirata to enhance its predictable growth potential.

 

 

Divestiture of DevOps Assets

Cirata announces today that it has signed an agreement to divest its DevOps assets to BlueOptima, a UK-based leading provider of software engineering performance insights, for a total consideration of up to $3.5m. The divestment includes DevOps products supporting Subversion, Gerrit and Git, enabling globally distributed developer teams to collaborate securely and efficiently with minimal latency. The transaction is expected to close on or around 8 August 2025, subject to customary closing conditions and approvals.

 

The total consideration of up to $3.5m will be paid in cash, with $2.5m payable on closing and up to $1.0m in December 2025, conditional on the successful transfer of Cirata's DevOps customers to BlueOptima.

 

On the sale of the assets, Cirata retains ownership of all existing intellectual property. As part of the transaction, BlueOptima will secure rights to the IP under an exclusive license agreement. Although profits have not been historically attributed to the DevOps product line, the business has continued to perform in line with the wider Group, reflecting consistency with historical cost structures and profitability trends. In FY24, DevOps revenue was $3.1m.

 

This divestiture signals a total focus on the growth potential of Cirata's DI business, the Company's core growth driver. Following this divestiture, Cirata aims to broaden the use cases for its Live Data Migrator ("LDM") product offering, leveraging the potential of Apache Iceberg open table formats to offer interoperability for unstructured data across the enterprise to the cloud. Important strategic relationships will provide an environment for collaboration on future Cirata data orchestration platform functionality. Data orchestration represents Cirata's vision for addressing the challenges of data modernization within the enterprise, evolving the product beyond Hadoop migration to multiple use cases for large-scale data modernization. 

 

 

Partnership Agreement

During Q2FY25, Cirata joined Microsoft's ASMP. Under the program, qualifying clients can register for migration to ADLS Gen 2 Storage for static migration using the Cirata LDM product. This represents another potential channel to market the LDM product and in the medium term, an opportunity to upsell Cirata's live data capabilities.

 

 

Cash and Overheads

The cash burn in Q2FY25 of $2.2m represents a 47% reduction compared to Q2FY24.

 

As of 30 June 2025, the unaudited cash position was $6.1m and short-term trade receivables balance was $1.3m, giving a cash plus short-term receivables balance of $7.4m. 

 

Management continues to focus on improving operating leverage and sustainability.

Actions will be taken in Q3 to reduce the annualized cash overhead to $12-13m exiting Q3FY25, representing a reduction of over 70% from a peak of $45m per annum (Q1FY23).

 

 

Key performance indicators

 

KPI

FY22 Q4

FY23 Q1

Q2

Q3

Q4

FY24 Q1

Q2

Q3

Q4

FY25

Q1

Q2

Headcount

177

193

127

109

112

116

107

92

93

71

67

Overhead

$11.1m

$9.4m

$8.2m

$7.0m

$5.7m

$6.2m

$5.5m

$5.3m

$3.8m

$4.6m

$4.1m

Bookings

$2.2m

$2.1m

$0.7m

$1.7m

$2.7m

$0.7m

$1.7m

$1.7m

$3.0m

$3.0m

$0.8m

DI Bookings

$1.2m

$0.2m

$0.4m

$0.5m

$1.5m

$0.3m

$0.6m

$1.4m

$2.3m

$2.4m

$0.7m

DI Growth

-43%

-87%

-69%

0%

25%

50%

50%

180%

51%

700%

  17%

DI Contract[1] Activity

2

2

4

4

3

4

1

8

6

5

2

Cash Burn

$10.3m

$11.0m

$6.3m

$7.9m

$5.5m

$4.9m

$4.2m

$3.2m

$3.2m

$1.4m

$2.2m

 

 

Stephen Kelly, Chief Executive Officer of Cirata, commented:

Sales execution in Q2 FY25 fell short of internal expectations, as several opportunities shifted into the second half of the year. However, actions taken earlier in the year to strengthen international sales began yielding results, as reflected in strong Q1 bookings. We flagged the poor sales execution in US sales at the Q1FY25 Trading Update and as we failed to see an improvement in performance in Q2 FY25, we have taken appropriate actions. In addition, with the appointment of our new Chief Revenue Officer, we have completed a challenging reorganization of our GTM function. I am confident that Dominic Arcari's appointment will address the sales execution challenge and put the sales basics in place as a foundation for predictable growth. We have seen improvements in lead generation and pipeline build during H1FY25, where marketing is becoming more effective and efficient. The first half of 2025 has seen a growth in bookings of 58% YoY, and it was encouraging to see 244% growth in DI sales YoY in the first half. With today's announcement of the divestiture of our legacy DevOps assets to BlueOptima, we signal a laser focus on our growth opportunity in DI, a strengthening of our balance sheet and further optimization of our cash overheads. We are confident that BlueOptima, with its expertise and focus on software engineering performance, is the right organization to take the DevOps products and team forward and wish them well on this exciting next phase. The outlook statement from March 2025 remains consistent and we anticipate sales will be back-end loaded for FY25. Cirata's technology is solving some of the biggest data challenges for customers in their quest to move petabyte scale dynamic data safely and securely embracing open-table formats. The demand for Gen AI and analytic consumption, means Cirata has a role to play at the heart of the data orchestration. We remain on course to exit FY25 on a growth trajectory."

 

 

This announcement contains inside information under the UK Market Abuse Regulation. The person responsible for arranging the release of this announcement on behalf of Cirata plc is Stephen Kelly, Chief Executive Officer.

 

For further information, please contact: 

Cirata

+1 (925) 380 1728

Stephen Kelly, Chief Executive Officer


Ricardo Moura, Chief Financial Officer


Daniel Hayes, Investor Relations




FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali




Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Brough Ransom / Ben Good




Panmure Liberum (Joint Broker)

+44 (0)20 3100 2000

Max Jones / John More


 

About Cirata 

Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated.

 

For more information about Cirata, visit www.cirata.com

 

 



[1] Data Integration contract signed included renewals, growth and new

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEASXSFAASEEA

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.